APA (7th ed.) Citation

Hayano, K., Watanabe, H., Ryuzaki, T., Sawada, N., Ohira, G., Kano, M., . . . Matsubara, H. Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy. Japan Surgical Society.

Chicago Style (17th ed.) Citation

Hayano, Koichi, Hiroki Watanabe, Takahiro Ryuzaki, Naoto Sawada, Gaku Ohira, Masayuki Kano, Masaya Uesato, and Hisahiro Matsubara. Prognostic Benefit of Conversion Surgery for HER2 Positive Stage IV Gastric Cancer; a Case Series Study of Eleven Patients Treated with Trastuzumab-based Chemotherapy. Japan Surgical Society.

MLA (9th ed.) Citation

Hayano, Koichi, et al. Prognostic Benefit of Conversion Surgery for HER2 Positive Stage IV Gastric Cancer; a Case Series Study of Eleven Patients Treated with Trastuzumab-based Chemotherapy. Japan Surgical Society.